Search PubMed⌕ Search

Biomedical subjects

J Hunziker

Publications and source records attributed to J Hunziker.

18 recordsLinked to original sources
PubMed2006

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

MicroRNAs (miRNAs) are endogenous 19-25 nucleotide RNAs that have recently emerged as a novel class of important gene-regulatory molecules involved in many critical developmental and cellular functions. miRNAs have been implicated in the pathogenesis of several human diseases, such as neurodegenerative disorders, cancer, and more recently in viral and metabolic diseases. Unraveling the roles of miRNAs in cellular processes linked to human diseases will lead to novel opportunities for the regulation of protein function and will help to evaluate their potential for therapeutic intervention. Approaches to interfere with miRNA function in vitro and in vivo based on synthetic anti-miRNA oligonucleotides (AMOs) are discussed in this review.

Animals↗
PubMed2000

Synthesis of aminoglycoside-modified oligonucleotides.

[structure: see text] To study the structural requirements of aminoglycoside binding to nucleic acids, compound 1-an analogue of the naturally occurring nucleoside J-was synthesized. When incorporated into oligodeoxynucleotides, 1 leads to thermal stabilization of the resulting duplexes. The increase in pairing affinity is stronger with complementary RNA than with DNA.

Aminoglycosides↗
PubMed2000

Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.

Anti-resorptive agents--including estrogen (E), calcitonin (CT), and bisphosphonates--are established in the treatment of osteoporosis. Intermittent administration of parathyroid hormone (PTH) stimulates bone formation and is a possible therapeutic agent for the restoration of bone mass. The purpose was to determine the effects of the anti-resorptive agents alone and in combination with intermittent PTH on bone formation in the mandible and a long bone in the aged ovariectomized (Ovx) rat. Female rats were ovariectomized or sham-operated. One year later, groups of Ovx rats were treated with E, CT, or the bisphosphonate, Risedronate (NE). Additional groups of Ovx rats were treated with each of these agents in combination with human PTH for 10 weeks. Estrogen treatment suppressed most indices of bone formation in the humerus and mandible, while NE decreased some indices of formation at the endocortical and endosteal surfaces of the mandible and humerus. Increased double-labeled surface and mineral apposition rates were observed only on the mandibular endosteal surfaces following CT treatment. When the anti-resorptive agents were combined with intermittent PTH, most indices of bone formation at all skeletal sites were substantially greater than those of the untreated Ovx controls as well as the E-, CT-, and NE-treated groups, respectively. These results provide additional evidence that established and emerging therapies for osteoporosis affect osseous tissues in the oral cavity, and this may influence the progression of diseases and/or aging changes at this site.

Analysis of Variance↗
PubMed1998

2'-Deoxy-2'(S)-ethinyl oligonucleotides: a modification which selectively stabilizes oligoadenylate pairing to DNA complements.

Oligonucleotides consisting of 2'-deoxy-2'(S)-ethinyl-thymidine,-uridine, and -adenosine have been prepared. Whereas the modified pyrimidine oligonucleotides uniformly lead to weaker pairing affinity with DNA and RNA complements, the corresponding adenine oligonucleotides show enhanced thermal stability in duplexes with complementary DNA and decreased stability with RNA.

Adenine Nucleotides↗
PubMed1997

Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats.

Intermittent administration of parathyroid hormone (PTH) is known to stimulate bone formation in many skeletal sites and is being investigated as a possible therapeutic agent for the treatment of osteopenic conditions, including post-menopausal osteoporosis. The purpose of this study was to determine the ability of PTH to stimulate bone formation in the mandibles of aged ovariectomized (Ovx) rats, and the results are compared with a site in the appendicular skeleton (humerus). The Ovx rat is a useful model of estrogen deficiency, replicating many aspects of post-menopausal osteoporosis. Female rats were ovariectomized or sham-operated, and one year later a group of the ovariectomized rats was treated with the 1-34 fragment of human PTH daily, five days a week for 10 weeks. During the experiment, the animals were given fluorochrome bone markers for histomorphometry. More than one year after ovariectomy or sham surgery, there were few differences in the histomorphometric indices of bone formation in the humerus or mandible. PTH treatment had no effect on dentin formation, measured in the mandibular incisor; however, most indices of bone formation-including the double-labeled surface, mineralizing surface, mineral appositional rate, new bone area, and surface-referent bone formation rates-were substantially greater in the PTH-treated group compared with both the Ovx and the Sham controls measured at the periosteal and endocortical surfaces of the humerus and the periosteal and cancellous bone surfaces of the mandible. In addition, bone formation at the alveolar crest, particularly on the buccal side, was greater in the PTH-treated group. The results from this study demonstrate that systemic intermittent PTH treatment stimulates bone formation in the mandibles in aged, estrogen-deficient animals.

Aging↗
PubMed1981

Small animal traversing gamma counter.

A whole body traverser was developed that provides a variety of radionuclide detection configurations for retention and distribution studies. Data from biologically incorporated radionuclides were shown to be less susceptible to geometrical problems with this whole body traverser than with the usual forms of whole body counters. When used in its fully rotational mode, the effects of photon energy and attenuation due to various body tissues, thicknesses, and radionuclide locations were minimized. Consistent presentation of all aspects of the sample produced greater than 95% correlation with the predictable data and less than 2% counting fluctuations. The whole body traverser was utilized in radiolabeled microsphere tracer studies for the determination of regional blood flow and as a static counter for long term retention studies.

Aging↗
PubMed1981

Evaluation of a new rat feeder for use in chemical toxicology and nutrition studies.

A rat feeder was designed, fabricated, and evaluated which eliminated many of the problems associated with commercially available rat feeders (such as inadequate feed capacity, excessive feed spillage, excessive feed contamination, and difficulties with cleaning feeders). The feeder was capable of holding up to 700 g of meal-type feed. It provided rats with a continuous supply of diet which was virtually free from feces and urine contamination. Feed waste due to spillage and inaccessible feed was minimal and estimated to average 0.8%. Growth and weight maintenance in weanling and adult rats using the feeder were similar when compared to rats receiving pelleted feed ad libitum.

Animal Feed↗
PubMed1975

A new feeder system for quantitating actual toxicant consumption by mice during feeding studies.

A new mouse feeder system was described which enables mice to be utilized for long-or short-term feeding studies of chemical toxicants. Quantitative toxicant consumption can be obtained. The use of granulated feed of particle size, 500-1000 mu, prevents bridging, thus assuring a constant supply of diet to the experimental animals. Comparative weight gain in female BALB/c Nctr BR mice showed no significant differences between the groups fed 500 ppm 2-fluorenylacetamide, control granulated feed, or pellets.

Acetamides↗
PubMedDate not supplied

Correlates of physical activity in chronic obstructive pulmonary disease.

BACKGROUND: Physical activity is a key dimension of functional status in people with chronic obstructive pulmonary disease (COPD), and the central target of interventions in this group. OBJECTIVES: To determine the relationships among functional performance measured as physical activity, functional capacity, symptom experiences, and health-related quality of life in people with COPD. METHOD: Cross-sectional, descriptive study. Convenience sample of 63 outpatients with COPD studied prior to entry into a pulmonary rehabilitation program. RESULTS: Daily physical activity, as measured by an accelerometer, was strongly associated with maximal distance walked during a 6-minute walk test (r = .60, p < .00), level of airway obstruction (r = .37, p < .01), walking self-efficacy (r = .27, p < .05), and physical health status (r = .40, p < .01). Physical activity was not correlated with self-report of functional status. The only predictor of physical activity was the 6-minute walk test. CONCLUSIONS: Accelerometer measurement of functional performance was most significantly related to walking abilities. This methodology represents a novel approach to measuring an important dimension of functional status not previously well quantified.

Activities of Daily Living↗